Drugs@FDA document
LIBTAYO Medication Guide · BLA 761097 SUPPL-16
Drugs@FDA document · REGENERON PHARMACEUTICALS · May 2, 2023
Key facts
| Drug name | LIBTAYO |
|---|---|
| Document type | Medication Guide |
| Application | BLA761097 |
| Submission | SUPPL-16 |
| Company | REGENERON PHARMACEUTICALS |
| Document date | May 2, 2023 |
| FDA document | accessdata.fda.gov |
At a glance
- Efficacy-Accelerated Approval Document categories
- 10–99 Documents for this application
- None USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: